A new initiative between IBM and JDRF, one of the leading groups funding the fight against type 1 diabetes, will apply machine learning to troves of worldwide research data accumulated over the years with the aim of uncovering commonalities that could point to diabetes risks in children.
The partnership is meant to give type 1 diabetes a foothold in emerging precision medicine efforts, officials say, combining JDRF’s global research with the computing power of IBM.
Scientists will start by examining three separate data sets, applying algorithms to help spotlight certain patterns or common factors that might identify ways to delay or prevent type 1 diabetes in kids.
